Movatterモバイル変換


[0]ホーム

URL:


DE7411543U - INHALER FOR POWDERED SUBSTANCES - Google Patents

INHALER FOR POWDERED SUBSTANCES

Info

Publication number
DE7411543U
DE7411543UDE7411543UDE7411543UDE7411543UDE 7411543 UDE7411543 UDE 7411543UDE 7411543 UDE7411543 UDE 7411543UDE 7411543 UDE7411543 UDE 7411543UDE 7411543 UDE7411543 UDE 7411543U
Authority
DE
Germany
Prior art keywords
inhaler
pump
capsule
perforating needle
locking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE7411543U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isf SpA Trezzano Sul Naviglio Mailand (italien)
Original Assignee
Isf SpA Trezzano Sul Naviglio Mailand (italien)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2257673Aexternal-prioritypatent/IT986056B/en
Priority claimed from IT2569873Aexternal-prioritypatent/IT1045851B/en
Application filed by Isf SpA Trezzano Sul Naviglio Mailand (italien)filedCriticalIsf SpA Trezzano Sul Naviglio Mailand (italien)
Publication of DE7411543UpublicationCriticalpatent/DE7411543U/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Description

Translated fromGerman

Dft. STE-H&» S. BESZEiJESDft. STE-H & »S. BESZEiJES

3 DAOHAU bsi MÜHCHEN3 DAOHAU to MÜHCHEN

Afci HcIDEVIEQ ?.
TELEPHON: DACHAU 43 71
Afci HcIDEVIEQ?.
TELEPHONE: DACHAU 43 71

P 6?IP 6? I

B e ω c b rB e ω c b r

zur Patentomieldungfor patent application

I.S.P. S.p.A.Trossano s/T.? (Hilano), ItalienI.S.P. Spa.Trossano s / T.? (Hilano), Italy

"betreffend"concerning

Inhalntor1 fib? pf:lvori*örnip;e Sv;batanaoaInhaler1 fib? pf: lvori * örnip; e Sv; batanaoa

Die Erfindung betrifft einen Inhalator sur Yera'breisvon pulverfönaigon AraneinittelnoThe invention relates to an inhaler sur Yera'breis from pulverfönaigon Araneinmittelo

IjS sind bereits Inhalatorea lator Vcrvxenclujig einerelastischen i'u'ape und einer !Tadel zun Durcb-Gtoßen einereino Arzneimittolsubstrma enthaltenden Kapsel.bekannt. !21all';cT;ioinon iat aber deren Arbaiten nicht völlig zufriedenstellend, ihre· Ausführung ziemlich, koapliüiex't und der Platzbedarfdurch ihre Ab-nenr.vinsen ^roß.Inhaler reactors with an elastic tape and a reprimand for pushing a capsule containing a drug substrate are already known. ! 21 all '; cT ; ioinon iat but their work is not completely satisfactory, their execution fairly, koapliüiex't and the space required by their ab-nenr.vinsen ^ roß.

-

7411543 05.OZ767411543 05.OZ76

OH.CTEPHAN Q. BESZEDEb PATENTANWALTOH. CTEPHAN Q. BESZEDEb PATENT ADVOCATE

806 DACHAU bei MÖNCHEN806 DACHAU near MÖNCHEN

POSTFACH 1.68PO Box 1.68

AM HEIDEWEG 2AM HEIDEWEG 2

TELEPHON: DACHAU 43 71TELEPHONE: DACHAU 43 71Postschsckkonto München (BLZ 700 100 80)Postschsckkonto Munich (bank code 700 100 80)

Konto-Nr. 136S 7tAccount no. 136S 7t

Bankkonto Nr. GO 637 bei der Kreis- und Stadtsparkasse Dacheil'iAdersdorf (BLZ 700 515 40)Bank account no.GO 637 at the Kreis- und Stadtsparkasse Dacheil'iAdersdorf (bank code 700 515 40)

22. Oktober 1975 G 74 115 43.8 P 672October 22, 1975 G 74 115 43.8 P 672

Die Bauteile 1 und 2 beziehungsweise 10 und 21 können alsgegenüber den anderen Bestandteilen des Inhalators beweglich angesehen werden, wie es aus einem Vergleich der Figuren 1und 4 hervorgeht.The components 1 and 2 or 10 and 21 can be viewed as movable with respect to the other components of the inhaler, as can be seen from a comparison of FIGS. 1 and 4.

Der Inhalator umfaßt ferner Anschlagmuffen 7i 7'» welchemit je einem inneren Anschlag 20, 20', von welchen jedermit einem Anschlag 19 beziehungsweise 19' des jeweiligen Perforiernadelhalterelementes2 beziehungsweise 2' zusammenwirkt, versehen sind, wie es insbesondere in Figur 1 dargestelltist. Die Anschlagmuffen 7, 71 sind durch Verklebenoder durch Rändelungen, wie es in Figur 3 dargestellt ist, an die bei 17 aneinandergeschraubten Kapselhalterteile 3j 4, welcheeinen Hohlraum 8 zur Aufnahme der Kapsel 16 bilden, starr befestigt. Beide Kapselhalterteile 3» 4 haben je einen Durchtritt18, 18', welche den Durchgang der Perforiernadeln 5, 51und von Luft gestatten. Um die Perforiernadel5,5' von derKapsel 16 getrennt zu halten, sind zwei Rückholfedern 21, 21' an den manteiförmigen Enden jedes Perforiernadelhalterelementes2, 21 in je einem ringförmigen Hohlraum zur Aufnahme vonzylindrischen Rückholfedern 21 beziehungsweise 21' zusammengedrücktangeordnet, so daß die Rückholfedern 21 beziehungsweise 21' zwischen dem Boden des Rückholfederhaltehohlraumesund den Enden der Verlängerung des Perforiernadelhalterelementes2 beziehungsweise 21 arbeiten. 14 ist eine Aus-The inhaler further comprises stop sleeves 7i 7 '' which are each provided with an inner stop 20, 20 ', each of which interacts with a stop 19 or 19' of the respective perforating needle holder element 2 or 2 ', as shown in particular in FIG . The stop sleeves 7, 71 are rigidly attached by gluing or knurling, as shown in FIG. Both capsule holder parts 3 »4 each have a passage 18, 18 ', whichallow the passage of the perforating needles 5, 5 1 and air. In order to keep the perforating needle5, 5 'separated from the capsule 16, two return springs 21, 21' are arranged pressed together at the jacket-shaped ends of each perforating needle holder element 2, 21 in an annular cavity for receiving cylindrical return springs 21 and 21 ', respectively that the return springs 21 and 21 'work between the bottom of the return spring holding cavity and the ends of the extension of the perforating needle holder element 2 and 21 , respectively. 14 is an

7411543 05.01767411543 05.0176

Der Erfindung· liegt die Aufgabe zugrunde, einenüber den angegebenen Stand der Technik vorbesserten Inhalatorvon einfacher Ausführung, rascher und sicherer Wirkung und verringerten Abmessungen zu schaffen.The invention · is based on the object of aInhaler improved over the stated state of the artof simple execution, quick and safe operation and reduced dimensions.

Die Erfindung geht von einem Inhalator für in einer mittels einer Perforiernadel zu durchstoßenden Kapsel enthaltenepi/lvürföraige Substanzen, welche mit Hilfe einerPumpe zu verteilen sind, mit eineia oberen Teil, an dessenEndQ die pulverförmige Substanz austritt, einem mittlerenTeil und einem unteren Teil aum Anschließen an die Pumpe aus. Die oben angeführte Problemstellung wird hierbei dadurchgelöst, daß der Inhalator durch ein ortsfestes mittleres Element als mittleren Teil, das von zwei, vorzugsx<reisedurch Verschrauben beziehungsweise eine Bajonettkupplung, miteinander zu verbindenden Kapselhalterteilen gebildet istund einen Hohlraum zur Aufnahme der Kapsel aufweist, und zwei gegeneinander bewegliche Perforiernadelhalterelementeim oberen Teil beziehungsweise unteren Teil, welche in die beiden. Kapselhalterteile gegen die Wirkung von Rückholfedernteleskopartig hineinbewegbar sind, gekennzeichnet ist.The invention relates to an inhaler for contained in a capsule to be pierced by means of a perforating needlepi / lvüröraige substances, which with the help of aPump are to be distributed, with an upper part on itsEndQ the powdery substance emerges, a middle onePart and a lower part for connecting to the pump. The above-mentioned problem is thereby solvedsolved that the inhaler through a stationary middle element as the middle part, which of two, preferred x <travelsis formed by screwing or a bayonet coupling to be connected to each other capsule holder partsand has a cavity for receiving the capsule, and two perforating needle holder elements which are movable relative to one anotherin the upper part and lower part, which in the two. Capsule holder parts against the action of return springsare telescopically movable in, is characterized.

Gemäß einer Ausgestaltung des Erfindungsgedankens ist es zweckmäßig, daß die beiden Kapselhalterteile des mittlerenElementes mit Anschlagmuffen nebst je einem inneren Anschlag,von welchen jeder in der Ruhestellung mit einem Anschlag des jeweiligen Perforiernadelhalterelementes inAnlage zu bringen ist, verbunden sind, vorzugsweise durch Verkleben beziehungsweise Reibungsverriegelung, und in derArbeitsstellung beziehungsweise beim Durchstoßen der Kapsel der Anschlag des jeweiligen Perforiernidelhalterelementesmit dem jeweiligen Kapselhalterteil in Anlage zu bringen ist.According to one embodiment of the inventive concept, it is expedient that the two capsule holder parts of the middleElement with stop sleeves plus one inner stop each,each of which in the rest position with a stop of the respective perforating needle holder element inIs to bring plant, are connected, preferably by gluing or friction locking, and in theWorking position or the stop of the respective perforating pin holder element when the capsule is piercedis to be brought into contact with the respective capsule holder part.

7411543 Q5.02J67411543 Q5.02J6

Eej ist auch gemäß einer weiteren Ausgestaltung vorteilhaft,daß die Roibun^sVerriogelung der Perforiorcad 1-halterelcsentomit dera oberen Clement beziehungsweisedem iliiaehluiostück des unteren üloLientoo für die Pu.ipc üox-jiodie Kupplun^sverriegelung der Anschlagmuffon. mit den Kapse1haltorteilen durch Hilcporippen mit Öägezühnen gebildetEej is also advantageous according to a further embodiment,that the Roibun ^ sVerriogelung the Perforiorcad 1-halterelcsentowith dera upper Clement respectivelythe iliiaehluio piece of the lower üloLientoo for the Pu.ipc üox-jiothe coupling lock of the stop muffon. with the caps 1holder parts formed by Hilcporippen with Öägezhnen

Vorzucstireise ist das untere Element des Inhalators vonsolcher Porin, daß bei ITichtp.etorauch der Inhalatorkorper innerhalbder Pumpe lamgekehrt» zweckmäßigerw iao bei aurrechterStellung der Purape nach unton, eingesetzt v/erdcn kann,wodurch eine beträchtliche Verrincei-uns des PlatKbodarfcsnebst Steigerung der Gebrauchsfähi^keit und ein gefällico^kompaktes Aussehen des Gerätes erreicht werden.Pre-travel is the lower element of the inhaler fromsuch a porin that at ITichtp.etorauch the inhalator body is withinthe pump turned upside down »more expediently w iao with aurgerePosition of the Purape towards Unton, can be inserted,thereby making a considerable verrincei-us des PlatKbodarfcsin addition to an increase in usability and a pleasing qualitycompact appearance of the device can be achieved.

Nach einer besonders vorteilhaften Ausführungsforn der Erfindung ist daher das Profil der zylindrischen Oberfläche dosunteren Teiles des Inhalators glatt beziehungsweise poliert und gleichförmig und von einem Vorsprung, an welchen das Mundstück der Pumpe durch Reibungsverriogolung in Anlage su bringen ist, unterbrochen. Dabei sind vorzugsweice die Berührungstellen der zylindrischen Oberfläche des unteren Teiles des Inhalator^ mit der geraden Oberfläche des Vorsprunges Verriegelungsstellenzur Reibungsverriegelung mit der Pumpe im gebrauchsbereiten Zustand des Inhalators. Auch sind vorzugsweisedie Berührunjsstellen der zylindrischen Oberfläche des unteren Teiles des Inhalators mit der gekrümmten Oberflächedes V.orsprung^s Verriegelungsstellcn zur Reibungsverriegeluugmit der Punpe im Ruhezustand des Inhalators.According to a particularly advantageous embodiment of the Erfinding is therefore the profile of the cylindrical surface doslower part of the inhaler smooth or polished and uniform and of a protrusion on which the mouthpart of the pump is brought into the system by frictional locking, interrupted. Touch is preferredmake the cylindrical surface of the lower part of the inhaler ^ locking points with the straight surface of the projectionfor frictional locking with the pump when the inhaler is ready for use. Also are preferredthe contact points of the cylindrical surface of the lower part of the inhaler with the curved surfaceof the protrusion of the locking position for friction lockingwith the pump while the inhaler is at rest.

Der erfindungsgemäße Inhalator wird an Hand des folgendenAusführungsbeispieles in Verbindung mit den beiliegenden Zeichnungen näher erläutert.The inhaler of the present invention is illustrated by the followingEmbodiment explained in more detail in connection with the accompanying drawings.

7411543 05.02.767411543 02/05/76

_ 4- —
Hierbei sind:
_ 4- -
Here are:

Figur 1 ein Lü;i;;cschnitt durch einen erfindun;;s~graiißon Inhalator in GruMctellui'^ beziehungsweisevor Ingebrauchnahme,Figure 1 a Lü; i ;; c section through an invention ;; s ~gray inhaler in GruMctellui '^ respectivelybefore use,

Figur 2 oin Schnitt längs der Linie II II vonFigure 2 o in section along the line II II of

Figur 1,Figure 1,

Figur 3 ein in Figur 1 enthaltener Kupplungsteil des erfindungGgemäßen Inhalators in demgegenübervergrößerter Darrteilung undFIG. 3 shows a coupling part of the inhaler according to the invention contained in FIG. 1 in contrastenlarged presentation and

Figur 4 der Inhalator vor Figur 1 nach Ingebrauchnahmebeziehungsweise nach den Durchstoßen einer darin enthaltenen Kapsel»FIG. 4 shows the inhaler in front of FIG. 1 after it has been usedor after piercing a capsule contained therein »

Gemäß den Figuren 1 und 4- umfaßt der Inhalator ein oberes Element 1, aus welchem ein von einer Kapsel 16 nach dem Durchstoßenverteiltes Pulver zum Ausströmen gebracht wird, und ein Anschlußstück beziehungsweise Mundstück 10 zum Anschließen desInhalators an eine herkömmliche Pumpe 15« Da die Pumpe 15 einegroße Zahl von Ausführungen haben kann, wird sie nicht näher beschrieben und ist nur schematisch dargestellt. In oberen Element1 beziehungsweise im Anschlußstück 10 sind Perforiernadelh^lterelementebeziehungsweise -anschlußstüclie 2, 2' befestigt, wobei die Verbindung durch Verkleben oder durch Kündelungen 13tderen Profile gemäß Figur 3 eine iieibungsverriegelung bewirken,herbeigeführt wird, wie uus Figur 2 hervorgeht, ist die Perforiernadel5 beziehungsweise 51 in dos Porforiornadelhultcrolcment2 beziehungsweise 2' hineingeschoben und wird durch vier radiale Rippen 9 beziehungsweise 91» welche neben dem Haltender Perforiernadel 5 beziehungsweise 5* den Durchgang von Luftgestatten, gehalten.According to FIGS. 1 and 4, the inhaler comprises an upper element 1, from which a powder distributed by a capsule 16 after being pierced is made to flow out, and a connector or mouthpiece 10 for connecting the inhaler to a conventional pump 15 Pump 15 can have a large number of designs, it is not described in detail and is only shown schematically. Perforiernadelh ^ lterelemente or -anschlussstüclie 2, 2 'are attached in the upper element 1 or in the connection piece 10, the connection being brought about by gluing or by means of bundles 13t whose profiles according to FIG Perforating needle 5 or 51 is pushed into dos Porforiornadelhultcrolcment 2 or 2 'and is held by four radial ribs 9 or 91 ' which, in addition to holding the perforating needle 5 or 5 *, allow air to pass through.

7411543 05.02.767411543 02/05/76

trittsöffnung für die Arzneimittel sub stanz und 22 der Einlaßfür die durch die Pumpe 15 gepumpte Luft·opening for the drug substance and 22 the inletfor the air pumped by the pump 15

AOAO

Die Rippen 9» 91 legen sowohl Luftdurchgänge fest als auchverbinden sie die Perforiernadelhalterung mit dem Körper des betreffenden Perforiernadelhalterelementes 2 beziehungsweise2'.The ribs 9 »91 both define air passages and connect the perforating needle holder to the body of the relevant perforating needle holder element 2 or 2 '.

In Figur 1 sind die inneren Anschläge 20, 20' der Anschlagmuffen7» 71 in Anlage mit den Anschlägen 19» 19' derPerforiernadelhalterelemente 2, 21 gezeigt, während sich inFigur 2 die Anschläge 19* 19' der Perforiernadelhalterelemente2, 21 mit den rohrförmigen Verlängerungen 6, 61 derKapselhalterelemente J, 4 in Anlage befinden.In Figure 1, the internal stops 20, 20 'of the stop sleeves 7 »71 into abutment with the stops 19' 19 'of the Perforiernadelhalterelemente 2 shown 21, while in Figure 2, the stops 19 * 19' of the Perforiernadelhalterelemente 2, 21 are in contact with the tubular extensions 6, 61 of the capsule holder elements J, 4.

In den Figuren 1 und 4 ist das Profil der zylindrischenOberfläcne des unteren Teiles 10 des Inhalatorkörpers, welcher durch Reibungsverriegelung mit der Pumpe 15 von geeignetenAbmessungen verbunden ist, glatt beziehungsweise poliert und gleichförmig und von einem Vorsprung 11, dessen Berührungsstellen 12, 12' mit der zylindrischen Oberfläche des unterenTeiles 10 des Inhalatorkörpers die Anschlagstellen zur Reibungsverriegelung mit der Pumpe 15 darstellen, wenn der Inhalatorgebrauchsbereit ist beziehungsweise nicht gebraucht wird, unterbrochen.In Figures 1 and 4, the profile is the cylindricalSurface of the lower part 10 of the inhaler body, which by frictional locking with the pump 15 of suitableDimensions is connected, smooth or polished and uniform and by a projection 11, the points of contact 12, 12 'with the cylindrical surface of the lowerPart 10 of the inhaler body represent the stop points for frictional locking with the pump 15 when the inhaleris ready for use or is not used, interrupted.

Die Arbeitsweise des Inhalators ist wie folgt:The way the inhaler works is as follows:

Zunächst wird der innerhalb der Pumpe 1.5 umgekehrt, zweckmäßigerweise bei aufrechter Stellung der Pumpe 15 nachunten, angeordnete Inhalatorkörper von der letzteren entfernt und innerhalb derselben durch Reibungsverriegelung in seinermit der Pompe 15 gleichsinnigen Anordnung, zweckmäßigerweisein aufrechter Stellung bei aufrechter Stellung der Pumpe 15, mit der Pumpe 15 verbundene Dann wird der Kapselhalterteil 4First, the inside of the pump 1.5 is reversed, expediently with the pump 15 in an upright positionbelow, located inhaler body removed from the latter and within the same by friction locking in itswith the Pompe 15 arrangement in the same direction, expedientlyin the upright position with the upright position of the pump 15, connected to the pump 15 Then the capsule holder part 4

— 1 —- 1 -

7411543 05.01767411543 05.0176

vom Kapselhalterteil 3 abgeschraubt und die Kapsel 16 eingesetzt,worauf das obere Element 1 und das Anschlußstück 10 des unteren Teiles gegeneinanderbewegt werden, das heißt eineVerkürzung beziehungsweise Stauchung des Inhalators längs der Pfeile A und B hervorgerufen wird, was zu zwei diametralentgegengesetzten Einstichen in die Kapsel 16 führt. Daher genügt es, die Pumpe 15 zu drücken, um den pulverförmigen Inhaltder Kapsel 16 in einsn Hohlraum von Mensch oder Tier, wie Nasenhöhlen beziehungsweise andere Hohlräume des menschlichenoder tierischen Körpers, einzuführen.unscrewed from the capsule holder part 3 and inserted the capsule 16,whereupon the upper element 1 and the connecting piece 10 of the lower part are moved towards one another, that is to say oneShortening or compression of the inhaler along the arrows A and B is brought about, resulting in two diametricalsopposite punctures in the capsule 16 leads. It is therefore sufficient to press the pump 15 to dispense the powdery contentthe capsule 16 in a cavity of humans or animals, such as nasal cavities or other cavities of the humanor animal body.

Aus dem Obigen geht die große Vereinfachung, welchedurch den erfindungsgemäßen Inhalator mit sehr wenigen Teilen erreicht wurde, weswegen der Zusammenbau nur mit sehrgeringen Kosten verbunden ist, hervor.From the above goes the great simplification, whichwas achieved by the inhaler according to the invention with very few parts, which is why the assembly only with verylow cost.

/11/ 11

SchutzansprücheProtection claims

7411543 05.01767411543 05.0176

Claims (6)

Translated fromGerman
1») Inhalator für in einer mittels einer Perforiernadelzu durchstoßenden Kapsel enthaltene pulverförmige Substanzen, welche mit Hilfe einer Pumpe zu verteilensind, mit einem oberen Teil, an dessen Ende die pulverförmige Substanz austritt, einem mittleren Teilund einem unteren Teil zum Anschließen an di© Pumpe, gekennzeichnet durch ein ortsfestes mittleresElement (3, 4) als mittleren Teil, das von zwei, vorzugsweise durch Verschrauben beziehungsweiseeine Bajonettkupplung, miteinander zu verbindenden (17) Kapseihalterteilen (3, 4) gebildet ist undeinen Hohlraum (8) zur Aufnahme der Kapsel (16) aufweist, und zwei gegeneinander bewegliche Perforiernadelhalterelemente(2, 21) im oberen Teil (1) beziehungsweise unteren Teil (10), welche in die beidenKappelhalterteile (3» 4) gegen die Wirkung vonRückholfedern (21, 21·) teleskopartig hineinbewegbarsind.1 ») Inhaler for powdery substances contained in a capsule to be pierced by means of a perforating needle, which are to be distributed with the aid of a pump, with an upper part, at the end of which the powdery substance emerges, a middle part and a lower part for connection to di © Pump, characterized by a stationary central element (3, 4) as the central part, which is formed by two (17) capsule holder parts (3, 4) to be connected to one another, preferably by screwing or a bayonet coupling, and a cavity (8) for Has receptacle of the capsule (16), and two perforatingneedle holder elements (2, 2 1 ) which can be moved relative to one another in the upper part (1) and lower part (10), which are inserted into the two cap holder parts (3 »4) against the action of return springs (21, 21 ·) can be moved in telescopically.2.) Inhalator nach Anspruch 1, dadurch gekennzeichnet, daß die beiden Kapselhalterteile (3, 4) des mittlerenElementes (3, 4) mit Anschlagmuffen (7, 7') nebst je einem inneren Anschlag (20, 2O')j von welchen jederon dar Ruhe stellung mit einem Anschlag (191 19')des jeweiligen Perforiernadelhalterelementes (2, 21)in Anlage zu bringen ist, verbunden sind, vorzugsweise durch Verkleben beziehungsweise Reibungsverriegelung,und in der Arbeitsstellung beziehungsweise beim Durchstoßen der Kapsel (16) der Anschlag (19>Ί9θdes jeweiligen Perforiernadelhalterelementes (2, 21) mit dem jeweiligen Kapselhalterteil (3 oder 4) in Anlagezu "bringen ist«2.) Inhaler according to claim 1, characterized in that the two capsule holder parts (3, 4) of the middle element (3, 4) with stop sleeves (7, 7 ') each together with an inner stop (20, 2O') j of which each on represents rest position with a stop (191 19 ') of the respective perforating needle holder element (2, 21 ) to be brought into abutment, are connected, preferably by gluing or friction locking, and in the working position or when the capsule (16) is pierced The stop (19> Ί9θ of the respective perforating needle holder element (2, 21 ) is to be brought into contact with the respective capsule holder part (3 or 4)7411543 05.02.767411543 02/05/76t ·t3.) Inhalator nach Anspruch 1 oder 2, dadurch gekennzeichnet,daß die Reibungsverriegelung der Perforiernadelhalterelemente(2, 21) mit dem oberen Element (1) beziehungsweise dem AnSchlußstück (10) des unterenElementes für die Pumpe (15) sowie die Kupplungsverrl?gelung der Ansehlagmuffen (7f 7') mit den Kapselhalterteilen(3, 4) durch Mikrorippen (9, 91) mit Sägrezahnen gebildet wird.3.) Inhaler according to claim 1 or 2, characterized in that the frictionlocking of the perforating needle holder elements (2, 2 1 ) with the upper element (1) or the connecting piece (10) of the lower element for the pump (15) and the clutch lock? gelation of the Ansehlagmuffen (7f 7 ') with the capsule holder parts (3, 4) is formed by micro-ribs (9, 91 ) with saw teeth.4.) Inhalator nach Anspruch 1 bis 3» dadurch gekennzeichnet,daß das Profil der zylindrischen Oberfläche seines unteren Teiles (10) glatt beziehungsweise poliertund gleichförmig ist und von einem Vorsprung (11), an welchen das Mundstück der Pumpe (15) durchReibungsverriegelung in Anlage zu bringen ist, unterbrochen ist.4.) Inhaler according to claim 1 to 3 »characterized in thatthat the profile of the cylindrical surface of its lower part (10) is smooth or polishedand is uniform and of a projection (11) on which the mouthpiece of the pump (15) passesFriction lock is to be brought into contact is interrupted.5·) Inhalator nach Anspruch 1 bis 4, dadurch gekennzeichnet,daß die Berührungsstellen (12) der zylindrischen Oberfläche seines unteren Teiles (10) mit der geradenOberfläche des Vorsprunges (11) Verriegelungsstellen zur Reibungsverriegelung mit der Pumpe (15) im gebrauchsbereitenZustand des Inhalators sind.5.) Inhaler according to claim 1 to 4, characterized in thatthat the points of contact (12) of the cylindrical surface of its lower part (10) with the straightSurface of the projection (11) locking points for friction locking with the pump (15) ready for useCondition of the inhaler.6.) Inhalator nach Anspruch Ibis 4, dadurch gekennzeichnet,daß die Berührungssreilen (12') der zylindrischenOberfläche seines unteren Teiles (10) mit der gekrümmten Oberfläche des Vorsprunges (11) Verriegelungsstellenzur Reibungsverriegelung mit der Pumpe (15) im Ruhezustand des Inhalators sind.6.) Inhaler according to claim Ibis 4, characterized in thatthat the contact ropes (12 ') of the cylindricalSurface of its lower part (10) with the curved surface of the projection (11) locking pointsfor frictional locking with the pump (15) when the inhaler is at rest.7411543 05.01767411543 05.0176
DE7411543U1973-04-041974-04-02 INHALER FOR POWDERED SUBSTANCESExpiredDE7411543U (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
IT2257673AIT986056B (en)1973-04-041973-04-04 INSUFFLATOR FOR POWDER-SHAPED MEDICATIONS
IT2569873AIT1045851B (en)1973-06-221973-06-22Inhaler for administering powdered medicaments - offers long term trouble free efficiency from particularly simple, inexpensive construction

Publications (1)

Publication NumberPublication Date
DE7411543Utrue DE7411543U (en)1976-02-05

Family

ID=26328226

Family Applications (2)

Application NumberTitlePriority DateFiling Date
DE2415961APendingDE2415961A1 (en)1973-04-041974-04-02 INHALER FOR POWDERED SUBSTANCES
DE7411543UExpiredDE7411543U (en)1973-04-041974-04-02 INHALER FOR POWDERED SUBSTANCES

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
DE2415961APendingDE2415961A1 (en)1973-04-041974-04-02 INHALER FOR POWDERED SUBSTANCES

Country Status (7)

CountryLink
US (1)US3906950A (en)
JP (1)JPS5048782A (en)
BE (1)BE813143A (en)
CH (1)CH569486A5 (en)
DE (2)DE2415961A1 (en)
FR (1)FR2224175B1 (en)
GB (1)GB1436813A (en)

Families Citing this family (213)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4069819A (en)*1973-04-131978-01-24Societa Farmaceutici S.P.A.Inhalation device
IT1017153B (en)*1974-07-151977-07-20Isf Spa APPARATUS FOR INHALATIONS
YU41046B (en)*1974-08-221986-10-31Schering AgMedicine inholating device
GB1521000A (en)*1975-06-131978-08-09Syntex Puerto Rico IncInhalation device
GB1562732A (en)*1976-02-101980-03-12Allen & Hanburys LtdDevice for dispensing medicaments
US4095596A (en)*1976-11-261978-06-20Smithkline CorporationNasal inhaler
IT1116047B (en)*1979-04-271986-02-10Sigma Tau Ind Farmaceuti DEVICE FOR THE QUICK INHALATION OF POWDER DRUGS BY PERSONS SUFFERING FROM ASTHMA
US4446862A (en)*1979-10-301984-05-08Baum Eric ABreath actuated devices for administering powdered medicaments
DE3345722A1 (en)*1983-12-171985-06-27Boehringer Ingelheim KG, 6507 Ingelheim INHALATOR
US4620847A (en)*1984-06-011986-11-04Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh PolimerovDevice for administering powdered substances
US4645487A (en)*1984-06-051987-02-24Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh PolimerovDevice for administering powdered substances
IT1222509B (en)*1987-08-171990-09-05Miat Spa INSUFFLATOR FOR THE ADMINISTRATION OF DRUGS IN THE FORM OF PRE-DOSED POWDER IN OPERATIONS
IT1228460B (en)*1989-02-231991-06-19Phidea S R L DISPOSABLE INHALER WITH PRE-PERFORATED CAPSULE
US6048857A (en)*1989-10-172000-04-11Ellinwood, Jr.; Everett H.Dosing method of administering medicaments via inhalation administration
IT1237118B (en)*1989-10-271993-05-18Miat Spa MULTI-DOSE INHALER FOR POWDER DRUGS.
DE4027391A1 (en)*1990-08-301992-03-12Boehringer Ingelheim Kg GAS-FREE INHALATION DEVICE
US7628339B2 (en)1991-04-242009-12-08Novartis Pharma AgSystems and methods for controlling fluid feed to an aerosol generator
US6540154B1 (en)1991-04-242003-04-01Aerogen, Inc.Systems and methods for controlling fluid feed to an aerosol generator
US5161524A (en)*1991-08-021992-11-10Glaxo Inc.Dosage inhalator with air flow velocity regulating means
DE4128295A1 (en)*1991-08-271993-03-04Pfeiffer Erich Gmbh & Co Kg DISCHARGE DEVICE FOR FLOWABLE MEDIA
DK198591D0 (en)*1991-12-101991-12-10Novo Nordisk As APPARATUS
EP0691864A4 (en)*1993-03-031996-07-03Tenax Corp POWDER DRUG HOLDER, FOR INHALER
US5388572A (en)*1993-10-261995-02-14Tenax Corporation (A Connecticut Corp.)Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en)*1993-12-021995-02-14Tenax CorporationDry powder inhalator medicament carrier
US5488946A (en)*1994-03-011996-02-06Calhoun; Clifford A.Emergency breathing device for opening cartridges
JP3372105B2 (en)*1994-05-262003-01-27株式会社日立ユニシアオートモティブ Inhalation type dispenser
AU3703895A (en)*1994-10-241996-05-15Oxford Biosciences LimitedParticle delivery
US5901703A (en)*1995-02-061999-05-11Unisia Jecs CorporationMedicine administering device for nasal cavities
JP3308425B2 (en)*1995-03-102002-07-29株式会社ユニシアジェックス Nasal administration device
US5758637A (en)*1995-08-311998-06-02Aerogen, Inc.Liquid dispensing apparatus and methods
US6085740A (en)1996-02-212000-07-11Aerogen, Inc.Liquid dispensing apparatus and methods
US6428771B1 (en)*1995-05-152002-08-06Pharmaceutical Discovery CorporationMethod for drug delivery to the pulmonary system
US5823183A (en)*1995-08-021998-10-20Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5988163A (en)*1995-08-021999-11-23Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
US5692496A (en)*1995-08-021997-12-02Innovative Devices, LlcDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6209538B1 (en)1995-08-022001-04-03Robert A. CasperDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
DE19533979A1 (en)*1995-09-141997-03-20Alfred Von Schuckmann Device for the dosed, airborne delivery of substances
JP3317827B2 (en)*1995-10-092002-08-26株式会社ユニシアジェックス Dosing device
US6013050A (en)*1995-10-202000-01-11Powderject Research LimitedParticle delivery
JP3328132B2 (en)*1996-03-212002-09-24株式会社ユニシアジェックス Inhaler type dispenser
AUPN976496A0 (en)*1996-05-101996-05-30Glaxo Wellcome Australia LtdUnit dose dispensing device
AU3273497A (en)*1997-06-231999-01-04Marco CecchiniInhaling device
JP3488620B2 (en)*1998-02-052004-01-19株式会社日立ユニシアオートモティブ Inhalation type dispenser
JP3530004B2 (en)*1998-02-062004-05-24株式会社日立ユニシアオートモティブ Inhalation type dispenser
US6257233B1 (en)*1998-06-042001-07-10Inhale Therapeutic SystemsDry powder dispersing apparatus and methods for their use
HK1042234A1 (en)1999-04-132002-08-09Nektar TherapeuticsPulmonary administration of dry powder formulations for treating infertility
EP2280020B1 (en)*1999-06-292016-02-17MannKind CorporationPharmaceutical formulations comprising a peptide complexed with a diketopiperazine
US9006175B2 (en)*1999-06-292015-04-14Mannkind CorporationPotentiation of glucose elimination
US7305986B1 (en)1999-07-232007-12-11Mannkind CorporationUnit dose capsules for use in a dry powder inhaler
US7464706B2 (en)*1999-07-232008-12-16Mannkind CorporationUnit dose cartridge and dry powder inhaler
US6235177B1 (en)1999-09-092001-05-22Aerogen, Inc.Method for the construction of an aperture plate for dispensing liquid droplets
JP4859320B2 (en)*1999-10-292012-01-25ネクター セラピューティックス Dry powder composition having improved dispersibility
DE19960459A1 (en)*1999-12-152001-06-21Pfeiffer Erich Gmbh & Co Kg Media Donor
US20010029947A1 (en)*1999-12-172001-10-18Steve PaboojianReceptacles to facilitate the extraction of powders
US7600511B2 (en)2001-11-012009-10-13Novartis Pharma AgApparatus and methods for delivery of medicament to a respiratory system
US6948491B2 (en)2001-03-202005-09-27Aerogen, Inc.Convertible fluid feed system with comformable reservoir and methods
US7971588B2 (en)2000-05-052011-07-05Novartis AgMethods and systems for operating an aerosol generator
US8336545B2 (en)2000-05-052012-12-25Novartis Pharma AgMethods and systems for operating an aerosol generator
US7100600B2 (en)*2001-03-202006-09-05Aerogen, Inc.Fluid filled ampoules and methods for their use in aerosolizers
MXPA02010884A (en)2000-05-052003-03-27Aerogen Ireland LtdApparatus and methods for the delivery of medicaments to the respiratory system.
US6948494B1 (en)*2000-05-102005-09-27Innovative Devices, Llc.Medicament container with same side airflow inlet and outlet and method of use
AU2001283546A1 (en)2000-08-142002-02-25Advanced Inhalation Research, Inc.Inhalation device and method
US6766799B2 (en)*2001-04-162004-07-27Advanced Inhalation Research, Inc.Inhalation device
US6732944B2 (en)2001-05-022004-05-11Aerogen, Inc.Base isolated nebulizing device and methods
US6681768B2 (en)2001-06-222004-01-27Sofotec Gmbh & Co. KgPowder formulation disintegrating system and method for dry powder inhalers
GB2380410B (en)*2001-10-052003-11-19Alchemy Healthcare LtdApparatus for the nasal or oral delivery of a medicament
ES2363333T3 (en)*2001-11-142011-08-01Novartis Ag AEROSOL SPRAYING DEVICE INCLUDING A CONNECTABLE BODY AND TERMINAL PIECE.
ATE508735T1 (en)2001-12-192011-05-15Novartis Ag PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
US7677467B2 (en)2002-01-072010-03-16Novartis Pharma AgMethods and devices for aerosolizing medicament
MXPA04006629A (en)2002-01-072004-11-10Aerogen IncDevices and methods for nebulizing fluids for inhalation.
WO2003059424A1 (en)2002-01-152003-07-24Aerogen, Inc.Methods and systems for operating an aerosol generator
ITMI20020078A1 (en)*2002-01-162003-07-16Fabrizio Niccolai DEVICE USABLE IN THE TREATMENT OF RESPIRATORY TRACT AFFECTIONS
ES2425392T3 (en)2002-03-202013-10-15Mannkind Corporation Cartridge for an inhalation device
JP3950738B2 (en)*2002-05-142007-08-01株式会社 バイオアクティス Nasal powder medicine administration device
US6915962B2 (en)2002-05-202005-07-12Aerogen, Inc.Apparatus for providing aerosol for medical treatment and methods
US20040206350A1 (en)*2002-12-192004-10-21Nektar TherapeuticsAerosolization apparatus with non-circular aerosolization chamber
US7638138B2 (en)2003-02-212009-12-29Translational Research, Ltd.Compositions for nasal administration of pharmaceuticals
US7278982B2 (en)2003-03-272007-10-09Bioactis LimitedPowder medicine applicator for nasal cavity
US8869794B1 (en)*2003-04-092014-10-28Novartis Pharma AgAerosolization apparatus with capsule puncturing member
EP1610850B2 (en)2003-04-092020-08-05Novartis AGAerosolization apparatus with air inlet shield
US8616195B2 (en)2003-07-182013-12-31Novartis AgNebuliser for the production of aerosolized medication
US7338171B2 (en)*2003-10-272008-03-04Jen-Chuen HsiehMethod and apparatus for visual drive control
JP2007517892A (en)*2004-01-122007-07-05マンカインド コーポレイション Methods for reducing serum proinsulin levels in type 2 diabetes
WO2005079755A2 (en)*2004-02-122005-09-01Nektar TherapeuticsInterleukin-13 antagonist powders, spray-dried particles, and methods
US20080090753A1 (en)*2004-03-122008-04-17Biodel, Inc.Rapid Acting Injectable Insulin Compositions
US7267121B2 (en)2004-04-202007-09-11Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7290541B2 (en)2004-04-202007-11-06Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7946291B2 (en)2004-04-202011-05-24Novartis AgVentilation systems and methods employing aerosol generators
CA2563365A1 (en)*2004-04-232005-11-03Mystic Pharmaceuticals, Inc.Multiple unit dose drug delivery system
US7727962B2 (en)*2004-05-102010-06-01Boehringer Ingelheim Pharma Gmbh & Co. KgPowder comprising new compositions of oligosaccharides and methods for their preparation
US7723306B2 (en)*2004-05-102010-05-25Boehringer Ingelheim Pharma Gmbh & Co. KgSpray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7611709B2 (en)*2004-05-102009-11-03Boehringer Ingelheim Pharma Gmbh And Co. Kg1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
KR20120131245A (en)2004-06-182012-12-04노파르티스 아게Methods of Treatment of Endobronchial Infections
JP4922762B2 (en)2004-08-102012-04-25株式会社新日本科学 Composition for nasal administration that is fast-acting and capable of high absorption
JP5078014B2 (en)2004-08-202012-11-21マンカインド コーポレイション Catalytic reaction of diketopiperazine synthesis.
PL2322180T3 (en)2004-08-232015-10-30Mannkind CorpDiketopiperazine salts for drug delivery
GB0420513D0 (en)*2004-09-152004-10-20Optinose AsPowder delivery devices
JP5188183B2 (en)*2004-11-102013-04-24シプラ・リミテッド Inhaler
US8524734B2 (en)2005-05-182013-09-03Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
DK2594272T3 (en)2005-05-182018-09-03Horizon Orphan Llc Aerosolized fluoroquinolones and their applications
US7614429B2 (en)*2005-05-182009-11-10Symyx Solutions, Inc.Apparatus and methods for storing and dispensing solid material
CA2607747C (en)2005-05-252015-12-01Aerogen, Inc.Vibration systems and methods
CN104324366B (en)2005-09-142016-10-05曼金德公司Method for preparation of drug based on improving the active agent affinity to crystalline microparticle surfaces
US8084420B2 (en)*2005-09-292011-12-27Biodel Inc.Rapid acting and long acting insulin combination formulations
US7713929B2 (en)2006-04-122010-05-11Biodel Inc.Rapid acting and long acting insulin combination formulations
WO2007041481A1 (en)*2005-09-292007-04-12Biodel, Inc.Rapid acting and prolonged acting insulin preparations
KR20080096809A (en)2006-02-222008-11-03맨카인드 코포레이션 Method for Improving Pharmaceutical Properties of Microparticles Containing Diketopiperazine and Active Agents
DE102006010089A1 (en)*2006-02-242007-10-18Aha-Kunststofftechnik Gmbh The dry powder inhaler
CA2649109A1 (en)*2006-04-122007-10-25Biodel, Inc.Rapid acting and long acting insulin combination formulations
EP1844805A1 (en)*2006-04-132007-10-17Boehringer Ingelheim Pharma GmbH & Co.KGInhaler
US7806117B2 (en)*2006-06-072010-10-05Shin Nippon Biomedical Laboratories, Ltd.Peroral powder delivery device
EP2029206A1 (en)*2006-06-162009-03-04Cipla LimitedImproved dry powder inhaler
US8337817B2 (en)2006-12-262012-12-25Shin Nippon Biomedical Laboratories, Ltd.Preparation for transnasal application
WO2008086413A2 (en)*2007-01-092008-07-17Mystic Pharmaceuticals, Inc.Intranasal cartridge devices
WO2008124522A2 (en)*2007-04-042008-10-16Biodel, Inc.Amylin formulations
GB2448183A (en)2007-04-052008-10-08Optinose AsNasal powder delivery device
US9248076B2 (en)2007-05-162016-02-02Mystic Pharmaceuticals, Inc.Dose dispensing containers
US8683995B2 (en)2007-05-162014-04-01Mystic Pharmaceuticals, Inc.Dose dispensing containers
CN105776119B (en)2007-05-162019-04-23神秘制药公司 Composition unit dose dispensing container
WO2008156586A2 (en)*2007-06-122008-12-24Alkermes, Inc.Inhalation device for powdered substances
EP2020249A1 (en)*2007-08-012009-02-04Boehringer Ingelheim Pharma GmbH & Co. KGInhalator
CN101801812B (en)*2007-09-142013-10-23神秘制药公司 Forming method of deep drawn container
US8785396B2 (en)2007-10-242014-07-22Mannkind CorporationMethod and composition for treating migraines
CA2703597A1 (en)*2007-10-252009-04-30Novartis AgPowder conditioning of unit dose drug packages
CA2711561A1 (en)*2008-01-042009-07-16Biodel, Inc.Insulin formulations for insulin release as a function of tissue glucose levels
EP2082769B1 (en)2008-01-242015-06-03Vectura Delivery Devices LimitedInhaler
ES2648196T3 (en)2008-02-072017-12-29The University Of Washington Circumferential spray device
BRPI0910875B8 (en)*2008-03-272021-06-22Mannkind Corp dry powder inhalation system
MY155524A (en)2008-06-132015-10-30Mannkind CorpA dry powder inhaler and system for drug delivery
US8485180B2 (en)2008-06-132013-07-16Mannkind CorporationDry powder drug delivery system
KR101628410B1 (en)2008-06-202016-06-08맨카인드 코포레이션An interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (en)2008-08-112016-05-11曼凱公司 Ultra-fast use of insulin
EP2341942A1 (en)2008-09-192011-07-13Nektar TherapeuticsPolymer conjugates of therapeutic peptides
US20110171312A1 (en)*2008-09-192011-07-14Nektar TherapeuticsModified therapeutic peptides, methods of their preparation and use
KR20160150110A (en)2008-10-072016-12-28랩터 파마슈티컬스 인코포레이티드Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en)2008-10-072014-01-14Mpex Pharmaceuticals, Inc.Topical use of Levofloxacin for reducing lung inflammation
US8314106B2 (en)2008-12-292012-11-20Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en)2009-03-032015-06-23Biodel Inc.Insulin formulations for rapid uptake
DK2405963T3 (en)2009-03-112013-12-16Mannkind Corp DEVICE, SYSTEM AND PROCEDURE FOR MEASURING RESISTANCE IN AN INHALATOR
WO2010131486A1 (en)*2009-05-152010-11-18Shin Nippon Biomedical Laboratories, Ltd.Intranasal pharmaceutical compositions with improved pharmacokinetics
KR20180079458A (en)2009-06-122018-07-10맨카인드 코포레이션Diketopiperazine microparticles with defined specific surface areas
WO2011013003A2 (en)*2009-07-312011-02-03Shin Nippon Biomedical Laboratories, Ltd.Intranasal granisetron and nasal applicator
LT2473170T (en)2009-09-042019-10-10Horizon Orphan Llc USE OF AEROSOLIZED LEVOFLOXACIN FOR THE TREATMENT OF Cystic Fibrosis
US9016147B2 (en)2009-11-032015-04-28Mannkind CorporationApparatus and method for simulating inhalation efforts
EP2498848A2 (en)2009-11-122012-09-19Stc.UnmDry powder inhaler with flutter dispersion member
BR112012033060A2 (en)2010-06-212018-02-27Mannkind Corp Dry powder drug release system methods
MX2012015292A (en)2010-06-242013-05-30Gilead Sciences IncPyrazolo [1, 5 -a] pyrimidines as antiviral agents.
US20120027752A1 (en)2010-07-222012-02-02Gilead Sciences, Inc.Methods and compounds for treating paramyxoviridae virus infections
TW201305185A (en)2010-09-132013-02-01Gilead Sciences Inc 2'-fluoro substituted carbon-nucleoside analog for antiviral therapy
JP6050758B2 (en)2010-12-072016-12-21レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. Dry powder inhaler and method of operating the same
WO2012106382A1 (en)2011-01-312012-08-09Genoa Pharmaceuticals, Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
JP6339371B2 (en)2011-03-032018-06-06インペル ニューロファーマ インコーポレイテッド Nasal drug delivery device
AU2012236150B2 (en)2011-04-012016-03-31Mannkind CorporationBlister package for pharmaceutical cartridges
JP6645735B2 (en)2011-05-092020-02-14インペル ニューロファーマ インコーポレイテッド Nose delivery nozzle
WO2012174472A1 (en)2011-06-172012-12-20Mannkind CorporationHigh capacity diketopiperazine microparticles
WO2013016784A1 (en)2011-08-042013-02-07Victor EsteveDry powder inhaler
AU2012328885B2 (en)2011-10-242017-08-31Mannkind CorporationMethods and compositions for treating pain
US10463815B2 (en)2012-02-212019-11-05Respira Therapeutics, Inc.Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
MX355267B (en)2012-03-132018-04-12Gilead Sciences Inc2'- substituted carba-nucleoside analogs for antiviral treatment.
PT2838900T (en)2012-04-172019-11-15Gilead Sciences IncCompounds and methods for antiviral treatment
WO2013184951A2 (en)*2012-06-062013-12-12Aerodesigns, Inc.Aerosol dispenser with replaceable cartridge
SG10201605800UA (en)2012-07-122016-09-29Mannkind CorpDry powder drug delivery system and methods
US10159644B2 (en)2012-10-262018-12-25Mannkind CorporationInhalable vaccine compositions and methods
US9757529B2 (en)2012-12-202017-09-12Otitopic Inc.Dry powder inhaler and methods of use
US9757395B2 (en)2012-12-202017-09-12Otitopic Inc.Dry powder inhaler and methods of use
AU2014228415B2 (en)2013-03-152018-08-09Mannkind CorporationMicrocrystalline diketopiperazine compositions and methods
JP2016520378A (en)2013-04-282016-07-14インペル ニューロファーマ インコーポレイテッド Medical unit dose container
EP3607941A1 (en)2013-04-302020-02-12Otitopic Inc.Dry powder formulations and methods of use
TWI568463B (en)2013-07-122017-02-01H 斯圖爾特 坎貝爾Mouthpiece for inhalers
BR112015031590B1 (en)2013-07-162021-05-18Victor Esteve powder inhaler
KR102465025B1 (en)2013-07-182022-11-09맨카인드 코포레이션Heat-stable dry powder pharmaceutical compositions and methods
US20150044288A1 (en)2013-07-312015-02-12Windward Pharma, Inc.Aerosol tyrosine kinase inhibitor compounds and uses thereof
WO2015021064A1 (en)2013-08-052015-02-12Mannkind CorporationInsufflation apparatus and methods
UA119050C2 (en)2013-11-112019-04-25Ґілеад Саєнсиз, Інк. PYROL [1.2-f] [1.2.4] TRIASINES USED FOR TREATMENT OF RESPIRATORY-SYNCITAL VIRAL INFECTIONS
NZ722927A (en)2014-01-102022-07-29Avalyn Pharma IncAerosol pirfenidone and pyridone analog compounds and uses thereof
JP6701086B2 (en)2014-02-202020-05-27オティトピック インコーポレイテッド Dry powder formulation for inhalation
USD752204S1 (en)2014-03-102016-03-22Civitas Therapeutics, Inc.Indicator for an inhaler
USD755367S1 (en)2014-03-102016-05-03Civitas Therapeutics, Inc.Indicator for an inhaler
USD752734S1 (en)2014-03-102016-03-29Civitas Therapeutics, Inc.Inhaler grip
US10307464B2 (en)2014-03-282019-06-04Mannkind CorporationUse of ultrarapid acting insulin
USD748242S1 (en)2014-07-112016-01-26H. Stuart CampbellInhaler mouthpiece
TWI678369B (en)2014-07-282019-12-01美商基利科學股份有限公司Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
TWI673283B (en)2014-08-212019-10-01美商基利科學股份有限公司2'-chloro aminopyrimidinone and pyrimidine dione nucleosides
US10561806B2 (en)2014-10-022020-02-18Mannkind CorporationMouthpiece cover for an inhaler
WO2016115379A1 (en)2015-01-142016-07-21Respira Therapeutics, Inc.Powder dispersion methods and devices
US10874139B2 (en)*2015-07-072020-12-29Altria Client Services LlcE-vapor device including capsule containing pre-vapor formulation
CA2998182A1 (en)2015-09-102017-03-16Impel Neuropharma, Inc.In-line nasal delivery device
US10940274B2 (en)2015-12-012021-03-09Cipla LimitedNasal spray assembly
JP6976970B2 (en)*2016-07-072021-12-08フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Nicotine inhaler system
US11744967B2 (en)2017-09-262023-09-05Shin Nippon Biomedical Laboratories, Ltd.Intranasal delivery devices
FR3072313B1 (en)*2017-10-122019-10-11Aptar France Sas DEVICE FOR DISPENSING FLUID PRODUCT
WO2019104192A1 (en)2017-11-212019-05-31Impel Neuropharma, Inc.Intranasal device with inlet interface
US11571532B2 (en)2017-11-212023-02-07Impel Pharmaceuticals Inc.Intranasal device with dip tube
EP3735244B1 (en)2018-01-052022-11-23Impel Pharmaceuticals Inc.Intranasal delivery of dihydroergotamine by precision olfactory device
WO2019136308A1 (en)2018-01-052019-07-11Impel Neuropharma, Inc.Intranasal delivery of olanzapine by precision olfactory device
JP2021532098A (en)2018-07-192021-11-25インペル ニューロファーマ インコーポレイテッド Respiratory tract delivery of levodopa and dopa decarboxylase inhibitors for the treatment of Parkinson's disease
CN109078245A (en)*2018-10-112018-12-25上海博极给药医药科技有限公司A kind of double-capsule type powder inhaler
US11759585B2 (en)2019-01-032023-09-19Impel Pharmaceuticals Inc.Nasal drug delivery device with detachable nozzle
KR20220010011A (en)2019-05-172022-01-25임펠 뉴로파마 인코포레이티드 Disposable nasal delivery device
PT4081305T (en)2019-12-242024-12-04Gilead Sciences IncDiacylglycerol kinase modulating compounds
TWI883391B (en)2020-02-182025-05-11美商基利科學股份有限公司Antiviral compounds
TWI874791B (en)2020-02-182025-03-01美商基利科學股份有限公司Antiviral compounds
TWI791193B (en)2020-02-182023-02-01美商基利科學股份有限公司Antiviral compounds
CA3171648A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
CN115698009B (en)2020-05-012025-04-08吉利德科学公司CD 73-inhibiting 2, 4-dioxopyrimidine compounds
WO2022240897A1 (en)2021-05-102022-11-17Sepelo Therapeutics, LlcPharmaceutical composition comprising delafloxacin for administration into the lung
JP7654118B2 (en)2021-06-232025-03-31ギリアード サイエンシーズ, インコーポレイテッド Diacylglycerol kinase modulating compounds
EP4359413A1 (en)2021-06-232024-05-01Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271677A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
JP7651018B2 (en)2021-06-232025-03-25ギリアード サイエンシーズ, インコーポレイテッド Diacylglycerol kinase modulating compounds
WO2023028364A1 (en)2021-08-272023-03-02Sepelo Therapeutics, LlcTargeted compositions and uses therof
EP4422756A1 (en)2021-10-292024-09-04Gilead Sciences, Inc.Cd73 compounds
GB2636208A (en)*2023-12-062025-06-11Industrial Design Consultancy LtdPowder dispensers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2307986A (en)*1940-02-151943-01-12BolteInsufflator
US2519555A (en)*1945-08-311950-08-22Abbott LabSterile medicament insufflator cartridge and insufflator
US2517482A (en)*1949-04-091950-08-01Sharp & Dohme IncInhaler
US2581182A (en)*1950-03-141952-01-01Abbott LabInhaler
US2946332A (en)*1957-12-231960-07-26Nysco Lab IncInsufflator
US3669113A (en)*1966-03-071972-06-13Fisons LtdInhalation device
US3507277A (en)*1966-09-171970-04-21Fisons Pharmaceuticals LtdInhalation device

Also Published As

Publication numberPublication date
US3906950A (en)1975-09-23
GB1436813A (en)1976-05-26
DE2415961A1 (en)1974-10-17
FR2224175B1 (en)1978-04-14
BE813143A (en)1974-07-31
FR2224175A1 (en)1974-10-31
CH569486A5 (en)1975-11-28
JPS5048782A (en)1975-05-01

Similar Documents

PublicationPublication DateTitle
DE7411543U (en) INHALER FOR POWDERED SUBSTANCES
DE60216265T2 (en) IMPROVEMENTS IN SPRAY MOUNTS
DE69503883T2 (en) LIQUID DISPENSER WITH REFILL
DE69206988T2 (en) Device for injecting a predetermined dose of a medium and method for filling this device
DE69507979T2 (en) Dispensing pump
DE69304320T2 (en) BLOOD DETECTION DEVICE
DE60212764T2 (en) inhaler
EP0827782B1 (en)Fluid dispenser
DE69712625T2 (en) discharge
DE2435186A1 (en) APPLICATION DEVICE FOR POWDERED DRUGS
DE10140704A1 (en) Process for mixing a poorly soluble pharmaceutical substance with a solvent and syringe to apply the process
DE7434592U (en) INHALER FOR POWDERED SUBSTANCES
DE19708406A1 (en) Device for dispensing substances
DE3342407A1 (en) INJECTION DEVICE
DE2825259C3 (en) Manually operated liquid atomizer
DE10011120A1 (en) Media Donor
DE69128720T2 (en) CORRECTION LIQUID DISPENSER
DE2719815A1 (en) MEDICAL SYRINGE
DE19622124A1 (en) Device for applying liquids
DE10323603A1 (en) Dosing device with a pump device
DE1475172A1 (en) Dosing and non-dosing aerosol spray head
DE2324296A1 (en) MIXING CONTAINER FOR DENTAL PREPARATIONS
EP2085147A1 (en)Device with pressure charged piston for dispensing a multiple syringe or multiple cartridge
DE8621877U1 (en) Fluid flow regulator for an intravenous delivery device
DE102013113791A1 (en) donor

[8]ページ先頭

©2009-2025 Movatter.jp